Egan-Jones Recommends Pacira Shareholders Support All Management Nominees
NEW YORK, June 5, 2026 /PRNewswire/ -- Egan-Jones recommends that shareholders of Pacira BioSciences vote FOR all three management nominees on the BLUE proxy card and AGAINST all three nominees put forward by DOMA Perpetual Capital Management LLC at the 2026 annual meeting. Egan-Jones'...
NEW YORK, June 5, 2026 /PRNewswire/ -- Egan-Jones recommends that shareholders of Pacira BioSciences vote FOR all three management nominees on the BLUE proxy card and AGAINST all three nominees put forward by DOMA Perpetual Capital Management LLC at the 2026 annual meeting. Egan-Jones'...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.